Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia

Pantothenic acid (vitamin B5) is an essential trace nutrient required for the synthesis of coenzyme A (CoA). It has previously been shown that pantothenic acid is significantly decreased in multiple brain regions in both Alzheimer’s disease (ADD) and Huntington’s disease (HD). The current investigat...

Full description

Bibliographic Details
Main Authors: Melissa Scholefield, Stephanie J. Church, Jingshu Xu, Stefano Patassini, Nigel M. Hooper, Richard D. Unwin, Garth J. S. Cooper
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/11/9/569
id doaj-c478ab4f1e094e158574b5baa876cff0
record_format Article
spelling doaj-c478ab4f1e094e158574b5baa876cff02021-09-26T00:40:40ZengMDPI AGMetabolites2218-19892021-08-011156956910.3390/metabo11090569Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease DementiaMelissa Scholefield0Stephanie J. Church1Jingshu Xu2Stefano Patassini3Nigel M. Hooper4Richard D. Unwin5Garth J. S. Cooper6Centre for Advanced Discovery & Experimental Therapeutics, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKCentre for Advanced Discovery & Experimental Therapeutics, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKCentre for Advanced Discovery & Experimental Therapeutics, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKSchool of Biological Sciences, Faculty of Science, University of Auckland, Private Bag 92 019, Auckland 1142, New ZealandDivision of Neuroscience & Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKCentre for Advanced Discovery & Experimental Therapeutics, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKCentre for Advanced Discovery & Experimental Therapeutics, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKPantothenic acid (vitamin B5) is an essential trace nutrient required for the synthesis of coenzyme A (CoA). It has previously been shown that pantothenic acid is significantly decreased in multiple brain regions in both Alzheimer’s disease (ADD) and Huntington’s disease (HD). The current investigation aimed to determine whether similar changes are also present in cases of Parkinson’s disease dementia (PDD), another age-related neurodegenerative condition, and whether such perturbations might occur in similar regions in these apparently different diseases. Brain tissue was obtained from nine confirmed cases of PDD and nine controls with a post-mortem delay of 26 h or less. Tissues were acquired from nine regions that show high, moderate, or low levels of neurodegeneration in PDD: the cerebellum, motor cortex, primary visual cortex, hippocampus, substantia nigra, middle temporal gyrus, medulla oblongata, cingulate gyrus, and pons. A targeted ultra–high performance liquid chromatography—tandem mass spectrometry (UHPLC-MS/MS) approach was used to quantify pantothenic acid in these tissues. Pantothenic acid was significantly decreased in the cerebellum (<i>p</i> = 0.008), substantia nigra (<i>p</i> = 0.02), and medulla (<i>p</i> = 0.008) of PDD cases. These findings mirror the significant decreases in the cerebellum of both ADD and HD cases, as well as the substantia nigra, putamen, middle frontal gyrus, and entorhinal cortex of HD cases, and motor cortex, primary visual cortex, hippocampus, middle temporal gyrus, cingulate gyrus, and entorhinal cortex of ADD cases. Taken together, these observations indicate a common but regionally selective disruption of pantothenic acid levels across PDD, ADD, and HD.https://www.mdpi.com/2218-1989/11/9/569pantothenic acidvitamin B5Parkinson’s disease dementiamass spectrometryAlzheimer’s diseaseHuntington’s disease
collection DOAJ
language English
format Article
sources DOAJ
author Melissa Scholefield
Stephanie J. Church
Jingshu Xu
Stefano Patassini
Nigel M. Hooper
Richard D. Unwin
Garth J. S. Cooper
spellingShingle Melissa Scholefield
Stephanie J. Church
Jingshu Xu
Stefano Patassini
Nigel M. Hooper
Richard D. Unwin
Garth J. S. Cooper
Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
Metabolites
pantothenic acid
vitamin B5
Parkinson’s disease dementia
mass spectrometry
Alzheimer’s disease
Huntington’s disease
author_facet Melissa Scholefield
Stephanie J. Church
Jingshu Xu
Stefano Patassini
Nigel M. Hooper
Richard D. Unwin
Garth J. S. Cooper
author_sort Melissa Scholefield
title Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
title_short Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
title_full Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
title_fullStr Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
title_full_unstemmed Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
title_sort substantively lowered levels of pantothenic acid (vitamin b5) in several regions of the human brain in parkinson’s disease dementia
publisher MDPI AG
series Metabolites
issn 2218-1989
publishDate 2021-08-01
description Pantothenic acid (vitamin B5) is an essential trace nutrient required for the synthesis of coenzyme A (CoA). It has previously been shown that pantothenic acid is significantly decreased in multiple brain regions in both Alzheimer’s disease (ADD) and Huntington’s disease (HD). The current investigation aimed to determine whether similar changes are also present in cases of Parkinson’s disease dementia (PDD), another age-related neurodegenerative condition, and whether such perturbations might occur in similar regions in these apparently different diseases. Brain tissue was obtained from nine confirmed cases of PDD and nine controls with a post-mortem delay of 26 h or less. Tissues were acquired from nine regions that show high, moderate, or low levels of neurodegeneration in PDD: the cerebellum, motor cortex, primary visual cortex, hippocampus, substantia nigra, middle temporal gyrus, medulla oblongata, cingulate gyrus, and pons. A targeted ultra–high performance liquid chromatography—tandem mass spectrometry (UHPLC-MS/MS) approach was used to quantify pantothenic acid in these tissues. Pantothenic acid was significantly decreased in the cerebellum (<i>p</i> = 0.008), substantia nigra (<i>p</i> = 0.02), and medulla (<i>p</i> = 0.008) of PDD cases. These findings mirror the significant decreases in the cerebellum of both ADD and HD cases, as well as the substantia nigra, putamen, middle frontal gyrus, and entorhinal cortex of HD cases, and motor cortex, primary visual cortex, hippocampus, middle temporal gyrus, cingulate gyrus, and entorhinal cortex of ADD cases. Taken together, these observations indicate a common but regionally selective disruption of pantothenic acid levels across PDD, ADD, and HD.
topic pantothenic acid
vitamin B5
Parkinson’s disease dementia
mass spectrometry
Alzheimer’s disease
Huntington’s disease
url https://www.mdpi.com/2218-1989/11/9/569
work_keys_str_mv AT melissascholefield substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia
AT stephaniejchurch substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia
AT jingshuxu substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia
AT stefanopatassini substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia
AT nigelmhooper substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia
AT richarddunwin substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia
AT garthjscooper substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia
_version_ 1716870116334895104